GH Research Plc (GHRS)
22.12
+0.35
(+1.61%)
USD |
NASDAQ |
May 22, 16:00
22.08
-0.04
(-0.16%)
After-Hours: 20:00
GH Research EPS Diluted (Quarterly) : -0.3057 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | -0.7087 |
| Atai Beckley, Inc. | -0.0833 |
| Avadel Pharmaceuticals Plc | 0.0002 |
| Jazz Pharmaceuticals Plc | 4.434 |
| Nektar Therapeutics | -1.815 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.97M |
| Total Expenses (Quarterly) | 18.97M |
| Enterprise Value | 1.251B |
| Earnings Yield | -4.11% |
| Normalized Earnings Yield | -4.565 |